Teva Wins US FDA Approval for Monthly Olanzapine Injection
Teva has announced US FDA approval of WELTRUZA for ER injectable suspension, as the first and only once-monthly subcutaneous injectable polanzapine for adults.
Injectable Suspension | 12/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy